South China Research Center for Stem Cell and Regenerative Medicine
7
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease
Role: lead
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia
Role: lead
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Fracture and Bone Nonunion
Role: lead
UCMSC Transplantation in the Treatment of Cartilage Damage
Role: lead
Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid
Role: lead
Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects
Role: lead
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)
Role: lead
All 7 trials loaded